We are live on ! Find out more
AMRI

Albany Molecular Research Inc
AMRI

Delisted

AMRI was delisted on the 31st of August, 2017.

Back to rankings

132 hedge funds and large institutions have $548M invested in Albany Molecular Research Inc in 2014 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 33 increasing their positions, 42 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,061% more call options, than puts

Call options by funds: $6.77M | Put options by funds: $583K

90% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 21

17% more funds holding

Funds holding: 113 → 132 (+19)

6% more capital invested

Capital invested by funds: $515M → $548M (+$32.2M)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

21% less repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 42

Holders
132
Holders Change
+19
Holders Change %
+16.81%
% of All Funds
3.79%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
40
Increased
33
Reduced
42
Closed
21
Calls
$6.77M
Puts
$583K
Net Calls
+$6.19M
Net Calls Change
+$2.55M

Top Buyers

Rank Fund Capital Flow
1
PIP
Permian Investment Partners
Texas
+$11.4M
2
BFA
BlackRock Fund Advisors
California
+$8.21M
3
CPIM
Columbia Partners Investment Management
Virginia
+$5.05M
4
DS
DRW Securities
Illinois
+$3.56M
5
SLCM
Seven Locks Capital Management
New York
+$3.52M

Top Sellers

Rank Fund Capital Flow
1
VAM
Visium Asset Management
New York
-$16.6M
2
BIM
Bogle Investment Management
Massachusetts
-$9.74M
3
BCM
Bridgeway Capital Management
Texas
-$6.27M
4
American Century Companies
American Century Companies
Missouri
-$3.55M
5
CBOA
Commonwealth Bank of Australia
Australia
-$3.05M
Name Holding Trade Value Shares
Change 		Change in
Stake
DS
26
DRW Securities
Illinois
$4.22M +$3.56M +210,000 New
SLCM
27
Seven Locks Capital Management
New York
$4.18M +$3.52M +207,537 New
Bank of New York Mellon
28
Bank of New York Mellon
New York
$4.03M +$1.21M +71,601 +56%
PPA
29
Parametric Portfolio Associates
Washington
$3.69M -$183K -10,784 -6%
HCMT
30
Highland Capital Management (Texas)
Texas
$3.24M +$41.3K +2,439 +2%
California Public Employees Retirement System
31
California Public Employees Retirement System
California
$2.89M -$1.05M -61,840 -30%
AA
32
Ancora Advisors
Ohio
$2.87M -$305K -18,000 -11%
Geode Capital Management
33
Geode Capital Management
Massachusetts
$2.77M -$147K -8,668 -6%
Two Sigma Investments
34
Two Sigma Investments
New York
$2.77M +$92.6K +5,467 +4%
SCM
35
Sterling Capital Management
North Carolina
$2.57M +$110K +6,465 +5%
Connor, Clark & Lunn Investment Management (CC&L)
36
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$2.35M -$996K -58,800 -35%
Principal Financial Group
37
Principal Financial Group
Iowa
$2.34M +$1.97M +116,247 New
Deutsche Bank
38
Deutsche Bank
Germany
$2.31M -$194K -11,473 -9%
GC
39
Guggenheim Capital
Illinois
$2.3M -$379K -22,369 -16%
TCIM
40
TIAA CREF Investment Management
New York
$2.14M +$87.7K +5,176 +5%
GAM
41
Gotham Asset Management
New York
$2.07M -$1.61M -94,837 -48%
Bessemer Group
42
Bessemer Group
New Jersey
$1.83M – – –
BIM
43
BlackRock Investment Management
Delaware
$1.78M +$143K +8,441 +11%
Ameriprise
44
Ameriprise
Minnesota
$1.62M +$1.36M +80,088 +34,080%
Charles Schwab
45
Charles Schwab
California
$1.19M -$1.05M -61,700 -51%
Asset Management One
46
Asset Management One
Japan
$1.19M – – –
AQR Capital Management
47
AQR Capital Management
Connecticut
$1.16M -$252K -14,900 -21%
RCM
48
Raptor Capital Management
Massachusetts
$1.15M +$967K +57,100 New
QI
49
QS Investors
New York
$1.14M +$960K +56,700 New
HK
50
Horizon Kinetics
New York
$1.13M – – –
1
2
3 4 5

AMRI Hedge Fund Activity: Q2 2014 in Review

132 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Albany Molecular Research Inc (AMRI) for Q2 2014, worth a combined $548M — up 6.3% from $515M a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new AMRI positions and 21 closed out — a net gain of 19 holders — while 33 added to existing stakes and 42 trimmed.

The largest buyer was Permian Investment Partners, opening a new position worth an estimated $11.4M. The largest seller was Visium Asset Management, cutting an estimated $16.6M.

  • 132 institutional investors held Albany Molecular Research Inc (AMRI) as of Q2 2014, up from 113 in Q1 2014.
  • Funds reported $548M of Albany Molecular Research Inc stock for Q2 2014, up 6.3% quarter-over-quarter.
  • 40 funds opened new Albany Molecular Research Inc positions in Q2 2014 and 21 closed out, a net change of +19 holders.
  • The largest Albany Molecular Research Inc buyer in Q2 2014 was Permian Investment Partners, an estimated $11.4M added.
  • The largest Albany Molecular Research Inc seller in Q2 2014 was Visium Asset Management, an estimated $16.6M sold.

Based on aggregated 13F filings for Q2 2014.